Experiment 614535

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

BLEOMYCIN

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIV
OrganismEmpty organism
CitationCASE JR,DC: YOUNG,CW: LEE III,BJ:. (1977). COMBINATION CHEMOTHERAPY OF MOPP-RESISTANT HODGKIN'S DISEASE WITH ADRIAMYCIN BLEOMYCIN, DACARBAZINE AND VINBLASTINE (ABDV).. 39()
Amount utilized
Compound isolated
Disease+ VINBLASTINE + ADRIAMYCIN + DECARBAZINE
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE